Vanderbilt Health placed 19th in the Gartner Healthcare Supply Chain Top 25 for 2025, released by Gartner Inc., a technology research and consulting firm.

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

Salazar shared his vision for the department and expressed gratitude to the Advisory Board members and supporters in the community.

The floor is named in recognition of Cal Turner Jr.’s support through the Cal Turner Family Foundation to bring pediatric inpatient rehabilitation closer to home.

The partnership builds on established exchanges and collaborations, as well as joint working groups between Vanderbilt partners, the Berlin Institute of Health at Charité (BIH) and the German Heart Center at Charité.

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.